Mortality and Risk Factors in Very Elderly Patients Who Start Hemodialysis: Korean Renal Data System, 2016–2020

医学 血液透析 比例危险模型 危险系数 内科学 终末期肾病 透析 体质指数 队列 死亡率 外科 肾脏疾病 置信区间
作者
Ji‐Hyeon Park,Hayne Cho Park,Do Hyoung Kim,Young Ki Lee,Ajin Cho
出处
期刊:American Journal of Nephrology [Karger Publishers]
卷期号:54 (5-6): 175-183 被引量:1
标识
DOI:10.1159/000530933
摘要

The number of elderly patients with end-stage renal disease (ESRD) is increasing worldwide. However, decision-making about elderly patients with ESRD remains complex because of the lack of studies, especially in very elderly patients (≥75 years). We examined the characteristics of very elderly patients starting hemodialysis (HD) and the associated mortality and prognostic factors.Data were analyzed retrospectively using a nationwide cohort registry, the Korean Renal Data System. Patients who started HD between January 2016 and December 2020 were included and divided into three groups according to age at HD initiation (<65, 65-74, and ≥75 years). The primary outcome was all-cause mortality during the study period. Risk factors for mortality were analyzed using Cox proportional hazard models.In total, 22,024 incident patients were included with 10,006, 5,668, and 6,350 in each group (<65, 65-74, and ≥75 years, respectively). Among the very elderly group, women had a higher cumulative survival rate than men. The survival rate was lower in patients with vascular access via a catheter than in those with an arteriovenous fistula or graft. Very elderly patients with more comorbid diseases had a significantly lower survival rate than those with fewer comorbidities. In the multivariate Cox models, old age, cancer presence, catheter use, low body mass index, low Kt/V, low albumin concentration, and capable status of partial self-care were associated with high risk of mortality.Preparation of an arteriovenous fistula or graft when starting HD should be considered in very elderly patients with fewer comorbid diseases.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
solarlad完成签到,获得积分10
刚刚
王檬发布了新的文献求助10
1秒前
爆米花应助科研通管家采纳,获得10
1秒前
1秒前
FashionBoy应助科研通管家采纳,获得30
1秒前
1秒前
零度蓝莓完成签到,获得积分10
1秒前
lili应助科研通管家采纳,获得10
1秒前
ale应助科研通管家采纳,获得10
1秒前
lili应助科研通管家采纳,获得10
1秒前
1秒前
2秒前
大胆的凌波完成签到,获得积分10
2秒前
2秒前
Eric完成签到,获得积分10
2秒前
lvyan完成签到,获得积分10
3秒前
风趣冷雁完成签到 ,获得积分10
3秒前
wlx完成签到,获得积分10
3秒前
清秀的孤菱完成签到 ,获得积分10
3秒前
可爱小蚱蜢完成签到,获得积分20
3秒前
鳗鱼落雁发布了新的文献求助10
3秒前
dongdong完成签到,获得积分10
3秒前
popo完成签到,获得积分10
4秒前
海与星完成签到,获得积分10
4秒前
4秒前
lv完成签到,获得积分10
4秒前
DMUXLW发布了新的文献求助10
5秒前
等等发布了新的文献求助10
6秒前
zinechoo发布了新的文献求助10
6秒前
gg完成签到,获得积分10
7秒前
simon完成签到,获得积分10
7秒前
隐形幻露完成签到,获得积分10
7秒前
研友_LN3xyn完成签到,获得积分10
7秒前
现代半莲完成签到,获得积分10
7秒前
科研通AI2S应助大胆的凌波采纳,获得10
7秒前
Orange应助星辰采纳,获得10
7秒前
云朗完成签到,获得积分10
8秒前
Nam楠完成签到,获得积分10
8秒前
ajiduo完成签到 ,获得积分10
8秒前
0009987完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Organic Reactions, Volume 116 1500
VALIDATION OF THE TAYLOR, ALAMEL AND VPSC MODELS FOR PLASTIC ANISOTROPY MODELING OF SHEET METALS 1000
Geist der Kunst und Kultur 1000
Middleton's Allergy Principles and Practice 10th Edition(Middleton's Allergy 2-Volume Set, 10th Edition) 1000
Resistance Spot Welding Dataset for Automobile Body-in-White Quality Analysis 748
日本現代怪異事典 副読本 700
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7402032
求助须知:如何正确求助?哪些是违规求助? 9006696
关于积分的说明 19174173
捐赠科研通 7035527
什么是DOI,文献DOI怎么找? 3231152
关于科研通互助平台的介绍 2393465
邀请新用户注册赠送积分活动 2212919